Western blot analysis further showed that cartilage generated from FOXO4-DRI pre-treated chondrocytes displayed higher protein levels of p16, p21, and p53 (Figure 3B)
and 2) the need to be manufactured by recombinant methods at high cost, thus limiting its widespread use
Neuroprotection Emerging Evidence Evidence Rating: Emerging (Interesting animal data, limited scope) Neurological applications show promise but require more research: Dopaminergic system protection Peripheral nerve regeneration Traumatic brain injury Alcohol-related neurological damage The GABAergic system interactions and NO modulation provide mechanistic support, but this area needs more study
Key specifications: Quantity: 5mg per vial Form: Lyophilised powder (unless stated otherwise) Appearance: White/offwhite (typical) Storage: Store cold, dry, protected from light/moisture (confirm per label/COA) Documentation: COA / SDS / lot number (where available) Intended use: Nonclinical laboratory research only
The GLOW Blend is a pre-blended formulation containing three peptides in a single vial: GHK-Cu 50mg (gene expression modulation, collagen synthesis, antioxidant upregulation) BPC-157 10mg (angiogenesis, growth factor signaling, fibroblast migration) TB-500 10mg (actin polymerization, cell migration, wound healing) Total content: 70mg per vial